PZU secures MetLife Ukraine approval as PZU stock costs EUR 16.50

Published on 10/21/2026 at 09:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ukraine approved PZU's MetLife deal for 100.00 percent of MetLife Ukraine on October 20, 2026. PZU stock costs EUR 16.50.

Regional expansion moves forward

Ukraine approved PZU's acquisition of MetLife Ukraine on October 20, 2026, covering 100.00 percent of the target.
PZU reported PLN 3.01 billion in first-half net profit, down 6.80 percent from the prior year.
PZU stock trades at EUR 16.50 at 9:40 a.m. CEST at Lang & Schwarz on October 21, 2026.

PZU, PLPZU0000011, Illustration mit AI erstellt.

PZU (PLPZU0000011) secured Ukrainian antitrust approval for its planned acquisition of MetLife Ukraine on October 20, 2026, a step toward expanding its life-insurance platform. The approval covers the purchase of 100.00 percent of MetLife Ukraine, as Interfax-Ukraine reported.

Approval advances regional expansion

The Ukrainian Antimonopoly Committee also approved provisions covering non-compete and employee non-solicitation obligations for three years. PZU signed the sale and purchase agreement with MetLife Global Holding Company II GmbH on April 30, 2026, while the transaction still requires approval from Ukraine's National Bank, according to Interfax-Ukraine.

PZU's existing Ukrainian operations had combined net assets of PLN 14 million as of June 30, 2026, compared with PLN 38 million at the end of 2025. MetLife Ukraine collected UAH 1.599 billion in insurance premiums during the first half of 2026, an 11.40 percent increase from the same period in 2025.

What does the deal mean for scale?

PZU's first-half results provide the operating backdrop. The company reported PLN 3.01 billion in net profit for the first half of 2026, down 6.80 percent year over year, while its investor-relations calendar lists the third-quarter report for November 19, 2026, and a conference for institutional investors on December 1, 2026, on the PZU investor-relations page.

Three dates define the transaction

On April 30, 2026, PZU signed the purchase agreement. As of June 30, 2026, its Ukrainian companies reported PLN 14 million in combined net assets. On October 20, 2026, Ukraine's antitrust authority approved the acquisition, according to Interfax-Ukraine.

PZU's next scheduled reporting date is November 19, 2026, for its third-quarter financial statement. The investor conference listed for December 1, 2026, is the next separately dated capital-markets event.

Stock price and pending approval

The remaining regulatory approval is the key near-term condition for closing. Trigon Dom Maklerski reported on October 19, 2026, that PZU's chief executive expected the MetLife Ukraine transaction to be finalized in the first quarter of 2027, subject to the required permissions.

PZU stock was trading at EUR 16.50 at Lang & Schwarz on October 21, 2026, at 9:40 a.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of PZU stock.